Why Is Ovid Therapeutics (OVID) Stock Down 69% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Ovid Therapeutics stock is down on Monday with heavy trading of OVID shares after the company reported a failed Phase3 clinical trial.

The post Why Is Ovid Therapeutics (OVID) Stock Down 69% Today? appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”